| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |